Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

Implementation of ultrasensitive HIV drug resistance tests for routine clinical use is hampered by uncertainty about the clinical relevance of drug-resistant minority variants. We assessed different detection thresholds for pretreatment drug resistance to predict an increased risk of virological failure.